Shanghai, China

Suoyuan Ji

This inventor holds 1 USPTO granted patent. Top assignee: Shanghai Keci Medical Technology Co., Ltd. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suoyuan Ji. Retrieved from https://idiyas.com/inventor/suoyuan-ji

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Suoyuan Ji: Innovator in Medical Technology

Introduction

Suoyuan Ji is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of medical technology, particularly through his innovative designs and patents. His work is characterized by a commitment to improving healthcare solutions.

Latest Patents

Suoyuan Ji holds a patent for a medical balloon, which showcases his expertise in developing advanced medical devices. This patent reflects his dedication to enhancing patient care and medical procedures.

Career Highlights

Currently, Suoyuan Ji is associated with Shanghai Keci Medical Technology Co., Ltd. His role in the company allows him to leverage his skills and knowledge in medical technology, contributing to the development of cutting-edge healthcare solutions.

Collaborations

Suoyuan Ji collaborates with talented individuals such as Fanqi Li and Zhichao Zhang. These partnerships foster innovation and drive the advancement of medical technologies.

Conclusion

Suoyuan Ji's contributions to medical technology through his patent and collaborations highlight his role as an influential inventor in the industry. His work continues to impact healthcare positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…